GABAPENTIN
NDC 69097-815, GABAPENTIN, capsule, from Cipla USA Inc..
- Product NDC
- 69097-815
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090705
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-815 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN400 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-815-07 | 69097081507 | 100 CAPSULE in 1 BOTTLE (69097-815-07) |
| 69097-815-12 | 69097081512 | 500 CAPSULE in 1 BOTTLE (69097-815-12) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9e4eca9c-6a2c-4ede-a252-1a27094bf594NADAC price for package 69097081507
GET /v1/drugs/nadac/69097081507
Use it
Look up 69097-815 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-815 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-815. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.